|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.85 INR | +0.61% |
|
-.--% | +36.88% |
| 05-30 | Novateor Research Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 04-30 | Novateor Research Laboratories Launches New Toothpaste | MT |
Company Valuation: Novateor Research Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 40.56 | 30.26 | 41.09 | 89.43 | 205.4 | 173.5 |
| Change | - | -25.39% | 35.78% | 117.65% | 129.62% | -15.51% |
| Enterprise Value (EV) 1 | 35.04 | 26.11 | 38.7 | 95.78 | 212 | 177.2 |
| Change | - | -25.47% | 48.22% | 147.47% | 121.35% | -16.4% |
| P/E | -420x | 313x | -18.1x | 231x | 850x | 256x |
| PBR | 0.47x | 0.35x | 0.52x | 1.13x | 2.34x | 1.65x |
| PEG | - | -2x | 0x | -2x | -22.7x | 1x |
| Capitalization / Revenue | 10.3x | 16.1x | 5.54x | 7.1x | 17x | 6.25x |
| EV / Revenue | 8.88x | 13.9x | 5.22x | 7.6x | 17.6x | 6.38x |
| EV / EBITDA | 26.8x | 23.8x | 13x | 62.8x | -64.3x | -136x |
| EV / EBIT | 100x | 190x | 18.2x | 144x | -51.6x | -60.8x |
| EV / FCF | -0.91x | -8.41x | -6.04x | -17.3x | -12.3x | -10.4x |
| FCF Yield | -110% | -11.9% | -16.5% | -5.78% | -8.16% | -9.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.02 | 0.02 | -0.47 | 0.08 | 0.05 | 0.14 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 3.947 | 1.878 | 7.419 | 12.6 | 12.07 | 27.77 |
| EBITDA 1 | 1.307 | 1.098 | 2.988 | 1.524 | -3.296 | -1.305 |
| EBIT 1 | 0.3497 | 0.1375 | 2.122 | 0.6664 | -4.108 | -2.914 |
| Net income 1 | -0.0789 | 0.118 | -2.284 | 0.3665 | 0.2927 | 0.818 |
| Net Debt 1 | -5.523 | -4.149 | -2.386 | 6.351 | 6.658 | 3.735 |
| Reference price 2 | 8.39 | 6.26 | 8.50 | 18.50 | 42.48 | 35.89 |
| Nbr of stocks (in thousands) | 4,834 | 4,834 | 4,834 | 4,834 | 4,834 | 4,834 |
| Announcement Date | 9/4/20 | 9/7/21 | 9/7/22 | 9/8/23 | 9/5/24 | 9/8/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.09M | |
| 21.8x | 4.24x | 15.52x | 2.88% | 345B | |
| 18.24x | 2.77x | 12.23x | 3.45% | 137B | |
| 25.16x | 3.76x | 15.81x | 2.29% | 73.76B | |
| 43.48x | 7.01x | 30.4x | 2.12% | 51.78B | |
| 20.63x | 2.88x | 11.93x | 4.33% | 37.54B | |
| 84.11x | 2.48x | 14.94x | 1.62% | 31.47B | |
| 18.42x | 1.33x | 7.94x | 1.29% | 19.68B | |
| 16x | 1.54x | 8.76x | 3.31% | 19.68B | |
| 21.31x | 1.53x | 9.79x | 2.43% | 18.47B | |
| Average | 29.91x | 3.06x | 14.15x | 2.64% | 73.45B | |
| Weighted average by Cap. | 25.35x | 3.75x | 15.25x | 2.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NOVATEOR Stock
- Valuation Novateor Research Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
